China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 5.06 billion. The enterprise value is 3.44 billion.
| Market Cap | 5.06B |
| Enterprise Value | 3.44B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
SHE:301333 has 95.99 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 95.99M |
| Shares Outstanding | 95.99M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | 12.32% |
| Owned by Institutions (%) | 17.12% |
| Float | 38.19M |
Valuation Ratios
The trailing PE ratio is 42.25 and the forward PE ratio is 30.49.
| PE Ratio | 42.25 |
| Forward PE | 30.49 |
| PS Ratio | 5.39 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.67 |
| P/FCF Ratio | 110.53 |
| P/OCF Ratio | 79.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.88, with an EV/FCF ratio of 75.14.
| EV / Earnings | 28.63 |
| EV / Sales | 3.66 |
| EV / EBITDA | 23.88 |
| EV / EBIT | 27.88 |
| EV / FCF | 75.14 |
Financial Position
The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.81 |
| Quick Ratio | 5.64 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.93 |
| Interest Coverage | 99.01 |
Financial Efficiency
Return on equity (ROE) is 6.26% and return on invested capital (ROIC) is 33.37%.
| Return on Equity (ROE) | 6.26% |
| Return on Assets (ROA) | 3.27% |
| Return on Invested Capital (ROIC) | 33.37% |
| Return on Capital Employed (ROCE) | 6.08% |
| Weighted Average Cost of Capital (WACC) | 6.42% |
| Revenue Per Employee | 355,125 |
| Profits Per Employee | 45,462 |
| Employee Count | 2,645 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 10.44 |
Taxes
In the past 12 months, SHE:301333 has paid 12.86 million in taxes.
| Income Tax | 12.86M |
| Effective Tax Rate | 9.53% |
Stock Price Statistics
The stock price has decreased by -0.45% in the last 52 weeks. The beta is 0.40, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -0.45% |
| 50-Day Moving Average | 53.72 |
| 200-Day Moving Average | 60.03 |
| Relative Strength Index (RSI) | 44.59 |
| Average Volume (20 Days) | 4,003,314 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 939.31 million and earned 120.25 million in profits. Earnings per share was 1.25.
| Revenue | 939.31M |
| Gross Profit | 295.11M |
| Operating Income | 123.45M |
| Pretax Income | 134.98M |
| Net Income | 120.25M |
| EBITDA | 137.41M |
| EBIT | 123.45M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 1.67 billion in cash and 42.52 million in debt, with a net cash position of 1.63 billion or 16.98 per share.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 42.52M |
| Net Cash | 1.63B |
| Net Cash Per Share | 16.98 |
| Equity (Book Value) | 2.01B |
| Book Value Per Share | 20.35 |
| Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was 63.60 million and capital expenditures -17.79 million, giving a free cash flow of 45.81 million.
| Operating Cash Flow | 63.60M |
| Capital Expenditures | -17.79M |
| Depreciation & Amortization | 13.96M |
| Net Borrowing | -5.78M |
| Free Cash Flow | 45.81M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 31.42%, with operating and profit margins of 13.14% and 12.80%.
| Gross Margin | 31.42% |
| Operating Margin | 13.14% |
| Pretax Margin | 14.37% |
| Profit Margin | 12.80% |
| EBITDA Margin | 14.63% |
| EBIT Margin | 13.14% |
| FCF Margin | 4.88% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | 0.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.84% |
| Buyback Yield | -1.20% |
| Shareholder Yield | -0.95% |
| Earnings Yield | 2.37% |
| FCF Yield | 0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |